Caribou Biosciences
CRBU
CRBU
126 hedge funds and large institutions have $338M invested in Caribou Biosciences in 2023 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
8.87% more ownership
Funds ownership: 71.3% → 80.17% (+8.9%)
4% more funds holding
Funds holding: 121 → 126 (+5)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
126
Holding in Top 10
2
Calls
$616K
Puts
$364K
Top Buyers
| 1 | +$20.5M | |
| 2 | +$16.7M | |
| 3 | +$15.7M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$15.3M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
+$14.1M |
Top Sellers
| 1 | -$2.81M | |
| 2 | -$2.31M | |
| 3 | -$2.13M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.85M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$689K |